注射器、針頭和導尿管市場：規模、細分市場、份額、法規、報銷、程序和到 2033 年的預測

注射器和針頭是用來將液體注入體內或從體內抽出液體的器械。 注射器由連接到空心管的針頭和滑動柱塞組成，有助於吸入和擠出液體。 注射器和針頭用於給患者註射液體和從患者體內抽取液體。 導尿管用於治療尿失禁、尿滯留和其他泌尿系統疾病的患者。 導尿管是一種從膀胱排出尿液的柔性管。 導尿管包括留置（福利）導尿管、間歇（短期）導尿管和外部（保險套）導尿管。

本報告詳細研究了全球注射器、針頭和導尿管市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢等。

目錄

注射器、針頭、導尿管及目前市場競爭狀況

• 對主要產業趨勢的見解
• 2015 年至 2033 年註射器、針頭及導尿管各細分市場的市場總收入及市場前景
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 注射器、針頭和導尿管市場的 SWOT 分析
• 注射器、針頭和導尿管市場的競爭動態見解和趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Abstract

Syringes, Needles, and Urinary Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Hospital Supplies therapeutic area.

The model discusses the effect of COVID -19 on the Syringes, Needles, and Urinary Catheters market for the year 2020 and beyond. Syringe and Needles are devices used to inject fluids into or withdraw fluids from the body. A Syringe consist of a needle which is attached to a hollow tube with a sliding plunger that can help to intake or push down the fluid. Syringes and Needles are used for administration of several fluids and drawing fluids in the patients. Urinary catheters are used to treat patients with urinary incontinence, urinary retention, or other urological disorders. A urinary catheter is a flexible tube which is used to drain urine from the bladder. Urinary catheters include indwelling (Foley) catheter, intermittent (short term) catheter, and external (condom) catheter.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Syringes, Needles, and Urinary Catheters and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Syringes, Needles, and Urinary Catheters market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Syringes, Needles, and Urinary Catheters market.
• Competitive dynamics insights and trends provided for Syringes, Needles, and Urinary Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Becton Dickinson and Co, Equashield LLC, Avanos Medical Inc, Cardinal Health Inc, Novo Nordisk AS, Teleflex Inc, Coloplast Corp, Stryker Corp, Medline Industries LP, Hollister Inc, Bioderm Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Syringes, Needles, and Urinary Catheters marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Syringes, Needles, and Urinary Catheters.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Syringes, Needles, and Urinary Catheters market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Syringes, Needles, and Urinary Catheters market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Syringes, Needles, and Urinary Catheters market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable